title: Strategy for improving retransplantation in the CyA era.
authors.affiliation: Department of Transplantation, Methodist Hospitals of Dallas, Texas 75265-5999.
authors.forename: R
authors.initials: R
authors.lastname: Dickerman
authors.forename: J
authors.initials: J
authors.lastname: Langley
authors.forename: K
authors.initials: K
authors.lastname: Brinker
authors.forename: G
authors.initials: G
authors.lastname: Trevino
authors.forename: L
authors.initials: L
authors.lastname: Melton
authors.forename: P
authors.initials: P
authors.lastname: Vergne-Marini
authors.forename: P K
authors.initials: PK
authors.lastname: Wilson
mesh_terms: D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006085:Graft Survival; D006680:HLA Antigens / Q000032:analysis; D006650:Histocompatibility Testing; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
chemical_list: D000961:Antilymphocyte Serum; D006680:HLA Antigens; D016853:Muromonab-CD3; D016572:Cyclosporine; D001379:Azathioprine; D011241:Prednisone